Recalls / Active ingredient / Rifampin

Rifampin

9 FDA drug recalls involving the active ingredient “Rifampin”.

Date	Class	Product	Firm
2024-01-11	Class II	Rifampin Capsules USP, 150 mg, 30 Capsules (3 x 10) unit doses per carton, Rx Only, Distributed by: American H	Amerisource Health Services LLC
2024-01-05	Class II	Rifampin Capsules USP 300mg, 30-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimor	Lupin Pharmaceuticals Inc.
2024-01-05	Class II	Rifampin Capsules USP 150mg, 30-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimo	Lupin Pharmaceuticals Inc.
2022-12-20	Class II	Rifampin Capsules USP, 300 mg, 100 Capsules (10 x 10) per carton, Rx Only, Distributed by: American Health Pac	Amerisource Health Services LLC
2022-12-12	Class II	Rifampin Capsules USP, 300 mg, 30-count bottle; Rx Only, Manufactured for: Lupin Pharmaceuticals Baltimore, Ma	Lupin Pharmaceuticals Inc.
2022-07-28	Class II	Rifampin Capsules, USP, 150 mg, 30 count HDPE bottles, Rx Only, Manufactured for Lupin Pharmaceuticals, Inc.,	Lupin Pharmaceuticals Inc.
2022-04-07	Class II	Rifampin for Injection, USP, 600 mg/vial, One Vial per carton, Rx only, Manufactured for: Mylan Institutional	Mylan Pharmaceuticals Inc
2019-10-07	Class II	Rifampin for Injection, USP, 600 mg/vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61	Mylan Laboratories Limited (Sterile Products Division)
2015-06-04	Class II	Rifampin for Injection, USP 600mg/vial in a 20mL vial, Rx only, Manufactured for Fresenius Kabi LLC 3 Corporat	Fresenius Kabi USA, LLC